Puma Biotechnology (PBYI) Reports $140.8M NERLYNX® Revenue in 2024 Amid Operational Excellence
Puma Biotechnology Inc. (PBYI) is a cutting-edge biopharmaceutical company dedicated to transforming cancer treatment through innovative therapies. Founded…